Darling Ingredients Inc. (DAR)

Intercept Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 28, 2025	Dec 28, 2024	Dec 30, 2023	Dec 31, 2022	Jan 1, 2022	Jan 2, 2021
Cash & Equivalents	94.58	75.97	126.5	127.02	68.91	81.62
Cash & Short-Term Investments	99.68	75.97	126.5	127.02	68.91	81.62
Cash Growth	-18.02%	-39.94%	-0.40%	84.33%	-15.57%	11.90%
Accounts Receivable	615.1	590.58	798.29	676.57	469.09	405.39
Other Receivables	24.05	35.06	23.6	18.58	1.08	3.88
Receivables	639.15	625.65	821.89	720.16	495.17	409.27
Inventory	605.33	576.84	758.74	673.62	457.47	405.92
Prepaid Expenses	80.35	81.29	105.66	85.67	53.71	47.79
Restricted Cash	27.5	37.58	0.29	0.32	0.17	0.1
Other Current Assets	43.22	42.11	42.59	31.32	13.6	42.29
Total Current Assets	1,495	1,439	1,856	1,638	1,089	986.99
Property, Plant & Equipment	3,019	2,924	3,141	2,648	1,996	2,010
Long-Term Investments	2,162	2,264	2,252	1,926	1,349	804.68
Goodwill	2,478	2,323	2,485	1,970	1,219	1,260
Other Intangible Assets	898.82	898.41	1,076	865.12	397.8	473.68
Long-Term Deferred Tax Assets	16.24	22.37	17.71	17.89	16.21	16.68
Other Long-Term Assets	205.28	199.59	234.96	136.27	66.8	60.68
Total Assets	10,275	10,070	11,061	9,202	6,134	5,613
Accounts Payable	365.74	348.71	425.59	472.49	307.12	255.34
Accrued Expenses	418.59	421.81	441	432.02	350.68	321.03
Current Portion of Long-Term Debt	19.84	128.94	60.7	69.85	24.41	27.54
Current Portion of Leases	66.63	66.84	55.33	49.23	38.17	39.46
Current Income Taxes Payable	14.7	9.72	15.52	44.85	32.31	17.5
Other Current Liabilities	79.4	67.48	-	-	-	14.44
Total Current Liabilities	996.7	1,044	998.14	1,068	752.68	675.31
Long-Term Debt	3,926	3,904	4,366	3,315	1,439	1,481
Long-Term Leases	172.1	157.61	154.9	141.7	120.31	109.71
Long-Term Deferred Tax Liabilities	283.34	293.02	498.17	481.83	362.94	276.21
Other Long-Term Liabilities	183.68	190.67	329.09	276.4	74.76	61.61
Total Liabilities	5,582	5,606	6,367	5,306	2,786	2,659
Common Stock	1.76	1.75	1.74	1.74	1.72	1.7
Additional Paid-In Capital	1,728	1,721	1,698	1,660	1,628	1,597
Retained Earnings	3,999	4,012	3,733	3,086	2,348	1,697
Treasury Stock	-718.92	-672.71	-629.01	-554.45	-374.72	-151.71
Comprehensive Income & Other	-396.26	-684.24	-198.35	-383.87	-321.69	-252.43
Total Common Equity	4,613	4,378	4,605	3,809	3,281	2,892
Minority Interest	79.77	86.48	88.26	87.47	66.83	62.3
Shareholders' Equity	4,693	4,464	4,694	3,896	3,348	2,954
Total Liabilities & Equity	10,275	10,070	11,061	9,202	6,134	5,613
Total Debt	4,217	4,257	4,637	3,576	1,622	1,657
Net Cash (Debt)	-4,117	-4,181	-4,511	-3,449	-1,553	-1,576
Net Cash Per Share	-25.77	-25.90	-27.78	-21.01	-9.29	-9.42
Filing Date Shares Outstanding	158.19	158.87	159.61	159.95	161.1	162.6
Total Common Shares Outstanding	158.19	158.9	159.53	159.97	160.79	162.2
Working Capital	498.54	395.93	857.53	569.65	336.33	311.69
Book Value Per Share	29.16	27.55	28.87	23.81	20.40	17.83
Tangible Book Value	1,237	1,157	1,045	973.52	1,664	1,158
Tangible Book Value Per Share	7.82	7.28	6.55	6.09	10.35	7.14
Land	-	203.51	217.11	201.57	161.24	170.24
Buildings	-	1,024	1,033	873.08	701.59	684.46
Machinery	-	3,626	3,558	3,132	2,638	2,532
Construction In Progress	-	440.65	487.34	310.18	194.77	179.1

Updated Jul 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q